-
1.
公开(公告)号:US20240294950A1
公开(公告)日:2024-09-05
申请号:US18390570
申请日:2023-12-20
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
IPC: C12P5/02 , C12N1/14 , C12N1/20 , C12N15/70 , C12N15/81 , C12P7/02 , C12P7/04 , C12P7/18 , C12P7/40 , C12P7/42 , C12P7/44 , C12P13/00 , C12P17/10
CPC classification number: C12P5/026 , C12N1/14 , C12N1/20 , C12N15/70 , C12N15/81 , C12P7/02 , C12P7/04 , C12P7/18 , C12P7/40 , C12P7/42 , C12P7/44 , C12P13/001 , C12P13/005 , C12P17/10 , Y02E50/30
Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms of the invention having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention. The invention still further provides a bioderived compound produced by a microbial organism of the invention, culture medium having the bioderived compound of the invention, compositions having the bioderived compound of the invention, a biobased product comprising the bioderived compound of the invention, and a process for producing a bioderived compound of the invention.
-
公开(公告)号:US20240124904A1
公开(公告)日:2024-04-18
申请号:US18453987
申请日:2023-08-22
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Priti Pharkya , Tae Hoon Yang , Jungik Choi
IPC: C12P7/18 , C07K14/245 , C12N1/20 , C12N9/00 , C12N9/02 , C12N9/12 , C12N9/16 , C12N9/52 , C12N9/88 , C12N15/52 , C12P7/42
CPC classification number: C12P7/18 , C07K14/245 , C12N1/20 , C12N9/0036 , C12N9/0057 , C12N9/1205 , C12N9/16 , C12N9/52 , C12N9/88 , C12N9/93 , C12N15/52 , C12P7/42 , C12Y106/01002 , C12Y110/03 , C12Y207/0104 , C12Y301/00 , C12Y301/02 , C12Y301/02002 , C12Y304/21092 , C12Y401/01031 , C12Y401/01032
Abstract: −The invention is directed to a non-naturally occurring microbial organism comprising a first attenuation of a succinyl-CoA synthetase or transferase and at least a second attenuation of a succinyl-CoA converting enzyme or a gene encoding a succinate producing enzyme within a multi-step pathway having a net conversion of succinyl-CoA to succinate.
-
公开(公告)号:US11708592B2
公开(公告)日:2023-07-25
申请号:US17120005
申请日:2020-12-11
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya , Mark J. Burk
IPC: C12P17/08 , C12N15/70 , C08G63/08 , C07D313/04 , C12N15/63 , C12P17/02 , C08G18/42 , C12N5/00 , C12N15/52
CPC classification number: C12P17/08 , C07D313/04 , C08G18/4277 , C08G63/08 , C12N5/0018 , C12N15/52 , C12N15/63 , C12N15/70 , C12P17/02
Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.
-
4.
公开(公告)号:US20230065295A1
公开(公告)日:2023-03-02
申请号:US17369871
申请日:2021-07-07
Applicant: Genomatica, Inc.
Inventor: Priti Pharkya , Anthony P. Burgard , Stephen J. Van Dien , Robin E. Osterhout , Mark J. Burk , John D. Trawick , Michael P. Kuchinskas , Brian Steer
IPC: C12N1/20 , C12P7/18 , C12N9/18 , C12N15/52 , C12P7/42 , C12N1/14 , C12N1/16 , C12N15/63 , C07C31/20 , C07C59/01 , C08G18/28 , C08G18/32 , C08G63/06 , C08G63/16 , C08G63/181 , C08G69/02
Abstract: The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate pathway and being capable of producing 4-hydroxybutyrate, wherein the microbial organism comprises one or more genetic modifications. The invention additionally provides methods of producing 4-hydroxybutyrate or related products using the microbial organisms.
-
5.
公开(公告)号:US20220333143A1
公开(公告)日:2022-10-20
申请号:US17526632
申请日:2021-11-15
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard
IPC: C12P7/64 , C12P7/6409 , C12P7/04 , C12P7/24 , C12N15/52 , C07C31/20 , C12N9/04 , C12N9/02 , C12N9/10 , C12N9/12 , C12N9/16 , C12N9/88 , C12N9/00
Abstract: The invention provides non-naturally occurring microbial organisms containing a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms selectively produce a fatty alcohol, fatty aldehyde or fatty acid of a specified length. Also provided are non-naturally occurring microbial organisms having a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms further include an acetyl-CoA pathway. In some aspects, the microbial organisms of the invention have select gene disruptions or enzyme attenuations that increase production of fatty alcohols, fatty aldehydes or fatty acids. The invention additionally provides methods of using the above microbial organisms to produce a fatty alcohol, a fatty aldehyde or a fatty acid.
-
公开(公告)号:US11293026B2
公开(公告)日:2022-04-05
申请号:US16550010
申请日:2019-08-23
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Priti Pharkya , Robin E. Osterhout
IPC: C12N1/21 , C12P7/44 , C12N9/04 , C12N9/12 , C12N9/10 , C12N9/88 , C12N9/02 , C12N9/16 , C12N15/52 , C12P13/00 , C12P13/02 , C12P17/10 , C12N9/80 , C12P7/46 , C12P7/62
Abstract: The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6-aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam.
-
公开(公告)号:US11180780B2
公开(公告)日:2021-11-23
申请号:US15616841
申请日:2017-06-07
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Mark J. Burk , Robin E. Osterhout , Priti Pharkya
IPC: C12N9/88 , C12N9/90 , C12P7/16 , C12N15/00 , C12P7/18 , C12N15/52 , C12N9/04 , C07C29/80 , C12N9/02 , C12N9/10
Abstract: A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2-one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl-CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.
-
8.
公开(公告)号:US20210332393A1
公开(公告)日:2021-10-28
申请号:US17064404
申请日:2020-10-06
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
IPC: C12P5/02 , C12P7/18 , C12N1/14 , C12N1/20 , C12P7/42 , C12P7/02 , C12P7/40 , C12N15/70 , C12N15/81 , C12P7/04 , C12P7/44 , C12P13/00 , C12P17/10
Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms of the invention having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention. The invention still further provides a bioderived compound produced by a microbial organism of the invention, culture medium having the bioderived compound of the invention, compositions having the bioderived compound of the invention, a biobased product comprising the bioderived compound of the invention, and a process for producing a bioderived compound of the invention.
-
公开(公告)号:US20210147881A1
公开(公告)日:2021-05-20
申请号:US16912409
申请日:2020-06-25
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Jun Sun , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.
-
公开(公告)号:US20210123078A1
公开(公告)日:2021-04-29
申请号:US16894600
申请日:2020-06-05
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Mark J. Burk , Robin E. Osterhout , Jun Sun , Priti Pharkya
Abstract: Provided herein is a non-naturally occurring microbial organism having a 1,3-butanediol (1,3-BDO) pathway and comprising at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. In some embodiments, the pathway includes reducing equivalents from CO or hydrogen. In certain embodiments, a 1,3-BDO pathway proceeds by way of central metabolites pyruvate, succinate or alpha-ketoglutarate. Also provided herein is a method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.
-
-
-
-
-
-
-
-
-